Perbandingan Efek Antiinflamasi antara Ekstrak Pare (M. Charantia) dengan Kortikosteroid terhadap Dermatitis Eksperimental pada Mencit secara Topikal
DOI:
https://doi.org/10.18196/mmjkk.v3i2.1700Keywords:
antiinflammation, corticosteroid, pare, immunocomprimisedAbstract
SARS (severe acute respiratory syndrome) represents how confusing the picture of inflammation is. In spite of its ability to protect our body, inflamma¬tion could have some disadvantages. Corticosteroid is one of symtomatically therapy for SARS. Corticosteroids itself has been used for a long time as antiinflammatory drug. But, its adverse reaction such immunocomprimised effect has limited its widely use. It was reported that a and b momorcharin from Pare has antiinflammatory activity. Momorcharin has an ability to prevent antigen-induced limfosit pro¬liferation and reduce the ability of macrofag to fagosit antigen. The aim of this research is to know how good the antiinflammatory effect of Pare comparing with hidrocortison’s is. The subject of this observation are mice as many as 22, which randomly divided into 4 groups. Each group had been injected with S. aureus subcutan. As soon as signs og infection appeared, we treated one group with Pare oint¬ment, one other group with hidrocortison, and 2 groups the rest as positive and negative control. The inflammation reaction in each group had been recorded, clinically and histologically. The datas were assessed with descriptively and qualitatifly analitic. The result was Pare itself had antiinflammatory effect. Topically, it could make inflammation reaction reduced, udema diminished, necrose not widened, healing time shorted and fibrosis prevented. But, still, its effect was not as strong as corticosteroid had. Neverthanless, all mice that had been treated with corticosteroid had died because of sepsis or immunocomprimised state, that Pare wouldn’t had.
Fenomena SARS (severe acute respiratory syndrome) mewakili gambaran hebatnya reaksi inflamasi, yang merupakan respon imun bermata dua. Pada satu sisi merupakan alat pertahanan tubuh, namun pada sisi yang lain dapat merugikan. Terapi simtomatis SARS salah satunya adalah pemberian metilprednisolon, yang merupakan golongan kortikosteroid. Sebagai antiinflamasi, kortikosteroid sudah digunakan setengah abad lamanya. Penggunaan kortikosteroid sebagai antiinflamasi dibatasi oleh efek samping yang ditimbulkannya, terutama penurunan status imun/ imunokompromised. Dilaporkan bahwa biji pare (M charantia) -mengandung zat a dan b momorcharin- mempunyai aktivitas antiinflamasi. In vitro momorcharin mampu menghambat proliferasi limfosit terinduksi antigen dan menurunkan fungsi fagosit dari makrofag. In vivo pada tikus mampu menghambat migrasi makrofag dan reaksi hipersensitifitas tipe lambat. Penelitian ini bertujuan untuk membandingkan efek antiinflamasi antara ekstrak Pare 10% dengan hidrokortison 1% secara topikal terhadap dermatitis eksperimental pada mencit. Subyek penelitian adalah mencit berjumlah 22 ekor, dibagi random menjadi empat kelompok: K (6 ekor), C (7 ekor) dan P (7 ekor,) masing-masing mendapat injeksi subkutan S. aureus 9 x 10,0ul. Terjadi infeksi lokal dengan angka kegagalan 5%. Mencit kelompok C mendapat terapi ointment Hidrokortison 1%, kelompok P oint¬ment ekstrak biji pare 10%, kelompok K tidak mendapat terap i/kontrol positif dan kelompok S (2 ekor) kontrol negatif. Pengukuran meliputi derajat peradangan -secara klinis dan histopatologi- serta kesembuhan yang dicapai. Analitisa data bersifat kualitatif deskriptif. Didapatkan hasil ekstrak biji pare mempunyai efek antiinflamasi. Pemberiannya secara topikal mampu memperlambat reaksi peradangan, mencegah akumulasi sel radang, meminimalisasi udema, mengurangi nekrosis, waktu pemulihan lebih cepat dan menghambat terbentuknya jaringan parut. Tetapi, efek antiinflamasi ekstrak biji pare masih lebih rendah dibandingkan dengan hidrokortison. Meskipun demikian seluruh mencit kelompok C/terapi hidrokortison mati dalam kondisi imunokompromised/sepsis.
References
Kresno, Siti Boedina, 1996, Imunologi: Diagnosis dan Prosedur Laboratorium, 3-9, FK-UI, Jakarta
Robbins, R. dan Kumar, 1992, Buku Ajar Patologi, 55-56, EGC, Jakarta
Soetaryo, 2003, SARS, Kedaulatan Rakyat
Soesatyo, Marsetyawan HNE and Mary Palmen, 1995, The Effects of Budesonide on Lymphoic and non-Lymphoid Cell Profiles and la-antigen Expression in Rats with Experimental Colitis BIKcd, 27, 1:13-9
Neal, MJ, 1993, Medical Pharmacology at a Glance, 89-90, Blackwell Scientific Publications Oxford, London
Leung SO, Yeung HW, Leung KN, 1987, The Immunosuppressive Activities of Two Abortifa cient Proteins Isolatedfrom the Seeds of Bitter Melon (Momordica ch.T Immunopharmacolog 13:159-71
Barbieri, 1992, RIPs in Cucurbitaceae, Gene, 139
Prascno, S. Suparwoto, Rintiswati, N. 1997, Antiviral Activity of Momordica charantia: A Prccliminary Study on in vitro Antiherpes Simpleks Virus, BIKed, 29,3:121-3
Soebowo, 1993, Immunobiologi, Dunia Angkasa, Bandung
Cuttmann, R.D. 1985, Immunology. 62-70, Scope Publicatins, New York
Jawetz, E. Adelberg, E.A. Melnick, J. Brooks, G.F. 1989, Medical Microbiology. 16th ed, 225- 7, Lange Medical Publications, Los Altos
Mandcll, G.L. 1977, Nctrophils and Infection, in: I look, E. and Mandcll. G.L. Current Concents of Infectious Disease, 71-84, Willey Medical Publication, New York
Sutarman, NP dan Roma, Julius, 1993, Pengaruh Kortikostcroid terhadap Sistem Imun, Cermin Dunia Kedokteran. 85:43-6
Douglas, P.F. 1981, Complement and Infectious Disease, 55-60, CRC Press
Downloads
Published
Issue
Section
License
Copyright
Authors retain copyright and grant Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) the right of first publication with the work simultaneously licensed under an Attribution 4.0 International (CC BY 4.0) that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
License
Articles published in the Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) are licensed under an Attribution 4.0 International (CC BY 4.0) license. You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
This license is acceptable for Free Cultural Works. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.